Why does the world’s most famous medical brand, Dr. Seuss, miss its deadline for a vaccine?
The world’s first anti-bacterial medicine that contains the same ingredient as a common pesticide, is now in development by a company that has raised $50 million in venture capital funding.
Dr. Seusseres new product, Dr Pepper, was first launched in 2011 and is now sold in the U.S., Europe and Australia.
It’s made with an ingredient called capsaicin, which is extracted from peppers, but also has been found to be toxic to the kidneys.
It is one of the most commonly used pesticides in the world and has been linked to a range of ailments including cancer, obesity and cardiovascular disease.
The U.N. Food and Drug Administration has said the pesticide is carcinogenic to humans.
The company says it’s in the early stages of testing the new drug.
Dr Pepper was designed to be used in the classroom.
It has a sweet flavor, but has no calories.
It’s also sold as a juice drink in vending machines, in grocery stores, and on grocery shelves.
But Dr Pepper has had a rocky rollout.
Last year, a lawsuit was filed by the American Civil Liberties Union against the makers of Dr Pepper over the use of capsaicins by the beverage industry, and the company has said it was the victim of a political attack.